Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Single-Arm Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT05109234 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT05109234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05109234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Single-Arm Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Lead sponsor
UCB Biopharma SRL
Phase
Phase 3
Overall status
Completed
Start date
March 30, 2022
Completion date
March 18, 2025
Enrollment
84 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

childhood absence epilepsy, juvenile absence epilepsy